Copyright Reports & Markets. All rights reserved.

Global Famciclovir API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Famciclovir API Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Insourced
    • 1.3.3 Outsourced
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Famciclovir API Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Tablet Product
    • 1.4.3 Capsule Product
    • 1.4.4 Others
  • 1.5 Global Famciclovir API Market Size & Forecast
    • 1.5.1 Global Famciclovir API Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Famciclovir API Sales Quantity (2019-2030)
    • 1.5.3 Global Famciclovir API Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Chongqing Shenghuaxi Pharma
    • 2.1.1 Chongqing Shenghuaxi Pharma Details
    • 2.1.2 Chongqing Shenghuaxi Pharma Major Business
    • 2.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Product and Services
    • 2.1.4 Chongqing Shenghuaxi Pharma Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Chongqing Shenghuaxi Pharma Recent Developments/Updates
  • 2.2 Aurobindo Pharma Limited
    • 2.2.1 Aurobindo Pharma Limited Details
    • 2.2.2 Aurobindo Pharma Limited Major Business
    • 2.2.3 Aurobindo Pharma Limited Famciclovir API Product and Services
    • 2.2.4 Aurobindo Pharma Limited Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Aurobindo Pharma Limited Recent Developments/Updates
  • 2.3 Apotex Pharmachem
    • 2.3.1 Apotex Pharmachem Details
    • 2.3.2 Apotex Pharmachem Major Business
    • 2.3.3 Apotex Pharmachem Famciclovir API Product and Services
    • 2.3.4 Apotex Pharmachem Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Apotex Pharmachem Recent Developments/Updates
  • 2.4 Changzhou Kony Pharma Co
    • 2.4.1 Changzhou Kony Pharma Co Details
    • 2.4.2 Changzhou Kony Pharma Co Major Business
    • 2.4.3 Changzhou Kony Pharma Co Famciclovir API Product and Services
    • 2.4.4 Changzhou Kony Pharma Co Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Changzhou Kony Pharma Co Recent Developments/Updates
  • 2.5 Teva Pharmaceutical Industries
    • 2.5.1 Teva Pharmaceutical Industries Details
    • 2.5.2 Teva Pharmaceutical Industries Major Business
    • 2.5.3 Teva Pharmaceutical Industries Famciclovir API Product and Services
    • 2.5.4 Teva Pharmaceutical Industries Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
  • 2.6 Olon
    • 2.6.1 Olon Details
    • 2.6.2 Olon Major Business
    • 2.6.3 Olon Famciclovir API Product and Services
    • 2.6.4 Olon Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Olon Recent Developments/Updates
  • 2.7 Fuan Pharmaceutical
    • 2.7.1 Fuan Pharmaceutical Details
    • 2.7.2 Fuan Pharmaceutical Major Business
    • 2.7.3 Fuan Pharmaceutical Famciclovir API Product and Services
    • 2.7.4 Fuan Pharmaceutical Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Fuan Pharmaceutical Recent Developments/Updates
  • 2.8 Zhejiang Charioteer Pharmaceutical
    • 2.8.1 Zhejiang Charioteer Pharmaceutical Details
    • 2.8.2 Zhejiang Charioteer Pharmaceutical Major Business
    • 2.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Product and Services
    • 2.8.4 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Zhejiang Charioteer Pharmaceutical Recent Developments/Updates
  • 2.9 Jialin Pharmaceutical
    • 2.9.1 Jialin Pharmaceutical Details
    • 2.9.2 Jialin Pharmaceutical Major Business
    • 2.9.3 Jialin Pharmaceutical Famciclovir API Product and Services
    • 2.9.4 Jialin Pharmaceutical Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Jialin Pharmaceutical Recent Developments/Updates
  • 2.10 Zhejiang Hisun
    • 2.10.1 Zhejiang Hisun Details
    • 2.10.2 Zhejiang Hisun Major Business
    • 2.10.3 Zhejiang Hisun Famciclovir API Product and Services
    • 2.10.4 Zhejiang Hisun Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Zhejiang Hisun Recent Developments/Updates
  • 2.11 Hetero
    • 2.11.1 Hetero Details
    • 2.11.2 Hetero Major Business
    • 2.11.3 Hetero Famciclovir API Product and Services
    • 2.11.4 Hetero Famciclovir API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Hetero Recent Developments/Updates

3 Competitive Environment: Famciclovir API by Manufacturer

  • 3.1 Global Famciclovir API Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Famciclovir API Revenue by Manufacturer (2019-2024)
  • 3.3 Global Famciclovir API Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Famciclovir API by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Famciclovir API Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Famciclovir API Manufacturer Market Share in 2023
  • 3.5 Famciclovir API Market: Overall Company Footprint Analysis
    • 3.5.1 Famciclovir API Market: Region Footprint
    • 3.5.2 Famciclovir API Market: Company Product Type Footprint
    • 3.5.3 Famciclovir API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Famciclovir API Market Size by Region
    • 4.1.1 Global Famciclovir API Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Famciclovir API Consumption Value by Region (2019-2030)
    • 4.1.3 Global Famciclovir API Average Price by Region (2019-2030)
  • 4.2 North America Famciclovir API Consumption Value (2019-2030)
  • 4.3 Europe Famciclovir API Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Famciclovir API Consumption Value (2019-2030)
  • 4.5 South America Famciclovir API Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Famciclovir API Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Famciclovir API Sales Quantity by Type (2019-2030)
  • 5.2 Global Famciclovir API Consumption Value by Type (2019-2030)
  • 5.3 Global Famciclovir API Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Famciclovir API Sales Quantity by Application (2019-2030)
  • 6.2 Global Famciclovir API Consumption Value by Application (2019-2030)
  • 6.3 Global Famciclovir API Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Famciclovir API Sales Quantity by Type (2019-2030)
  • 7.2 North America Famciclovir API Sales Quantity by Application (2019-2030)
  • 7.3 North America Famciclovir API Market Size by Country
    • 7.3.1 North America Famciclovir API Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Famciclovir API Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Famciclovir API Sales Quantity by Type (2019-2030)
  • 8.2 Europe Famciclovir API Sales Quantity by Application (2019-2030)
  • 8.3 Europe Famciclovir API Market Size by Country
    • 8.3.1 Europe Famciclovir API Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Famciclovir API Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Famciclovir API Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Famciclovir API Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Famciclovir API Market Size by Region
    • 9.3.1 Asia-Pacific Famciclovir API Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Famciclovir API Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Famciclovir API Sales Quantity by Type (2019-2030)
  • 10.2 South America Famciclovir API Sales Quantity by Application (2019-2030)
  • 10.3 South America Famciclovir API Market Size by Country
    • 10.3.1 South America Famciclovir API Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Famciclovir API Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Famciclovir API Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Famciclovir API Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Famciclovir API Market Size by Country
    • 11.3.1 Middle East & Africa Famciclovir API Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Famciclovir API Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Famciclovir API Market Drivers
  • 12.2 Famciclovir API Market Restraints
  • 12.3 Famciclovir API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Famciclovir API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Famciclovir API
  • 13.3 Famciclovir API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Famciclovir API Typical Distributors
  • 14.3 Famciclovir API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
    According to our (Global Info Research) latest study, the global Famciclovir API market size was valued at US$ 13.7 million in 2023 and is forecast to a readjusted size of USD 16 million by 2030 with a CAGR of 2.2% during review period.
    The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
    Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
    Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
    Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
    This report is a detailed and comprehensive analysis for global Famciclovir API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Famciclovir API market size and forecasts, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/KG), 2019-2030
    Global Famciclovir API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/KG), 2019-2030
    Global Famciclovir API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/KG), 2019-2030
    Global Famciclovir API market shares of main players, shipments in revenue ($ Million), sales quantity (KG), and ASP (US$/KG), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Famciclovir API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Famciclovir API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, Olon, Fuan Pharmaceutical, Zhejiang Charioteer Pharmaceutical, Jialin Pharmaceutical, Zhejiang Hisun, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Famciclovir API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Insourced
    Outsourced
    Others
    Market segment by Application
    Tablet Product
    Capsule Product
    Others
    Major players covered
    Chongqing Shenghuaxi Pharma
    Aurobindo Pharma Limited
    Apotex Pharmachem
    Changzhou Kony Pharma Co
    Teva Pharmaceutical Industries
    Olon
    Fuan Pharmaceutical
    Zhejiang Charioteer Pharmaceutical
    Jialin Pharmaceutical
    Zhejiang Hisun
    Hetero
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Famciclovir API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Famciclovir API, with price, sales quantity, revenue, and global market share of Famciclovir API from 2019 to 2024.
    Chapter 3, the Famciclovir API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Famciclovir API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Famciclovir API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Famciclovir API.
    Chapter 14 and 15, to describe Famciclovir API sales channel, distributors, customers, research findings and conclusion.

    Buy now